PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer - Wikidata - awgldk - TriplyDB

PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer

PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer

http://www.wikidata.org/entity/Q35236785

about

Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer.Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.Aspirin exerts high anti-cancer activity in PIK3CA-mutant colon cancer cells.Notch signaling via regulation of RB and p-AKT but not PIK3CG contributes to MIA PaCa-2 cell growth and migration to affect pancreatic carcinogenesis.Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology.Evaluation of PIK3CA mutations as a biomarker in Chinese breast carcinomas from Western China.

P2860

Q28084346-42C32374-5ADD-4A7D-86E3-DA799CC6D2A0 Q30248900-BE3B7747-0988-4758-B6F1-99C4391D62CB Q37525272-3B9D3FE3-AD77-442B-8B5C-EFD59E8A3FF4 Q40198390-D75DBCFC-5BC4-44CB-8B16-4440A92CCB62 Q40235695-29477E2F-0527-48B3-B831-A1DB0EE55D6E Q40603067-C271FAF1-85CD-4654-B4AF-76CE6273F493 Q47171553-7666BC45-06D3-4445-BE47-8AEF67F1A2C4 Q50053626-FF13343E-0505-4500-B5F7-998834148CCF Q53601791-940DBEE0-BD49-4E4A-B0EE-949C614CD1D2 Q55003988-724BEB1E-B44E-4E7D-8F4E-94B892135684

P2860

PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer

http://www.wikidata.org/entity/Q35236785

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer

@ast

PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer

@en

type

label

PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer

@ast

PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer

@en

prefLabel

PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer

@ast

PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer

@en

P1433

Q35236785-1B79D098-74EE-4D59-8050-E53F4B28F663

P1476

Q35236785-3EC43D45-E802-4915-811D-EE44582EA216

P2093

Q35236785-1D4CBB0D-B678-4079-B9D8-7D49D3BE797E

Q35236785-51887A77-317B-466D-BE1C-D5FC2FFCB3CA

Q35236785-544DD7CD-BA1A-44B1-BCAE-E57CCAACAE15

Q35236785-74641F0E-D537-45BF-A89A-C98E1EA321A0

Q35236785-7C993E58-61C5-485D-965E-52EAF5FED1E9

Q35236785-9507BFA0-0607-4582-A718-B70526A75EB7

Q35236785-992E034F-7ED8-4F8B-A5AD-B3B87A56FD7D

Q35236785-BC46008C-184D-4AD7-9FBF-58942354BBD9

Q35236785-D0C66E3D-469C-4F2B-B6F2-4F1A36D53DF5

Q35236785-D1996D36-04A9-4851-A8D3-C2FFF85343CA

P2860

Q35236785-047084CF-7C58-4850-99A6-2966C86E36E0

Q35236785-049277D3-2896-4DDF-835E-9724D140C145

Q35236785-059EEA3B-D4E7-4144-9728-D4E7E22D2E6A

Q35236785-078B7870-DF77-4C84-AC3C-022A5B88412F

Q35236785-0B7C8470-0431-46D1-9857-C8EC4E95AFA4

Q35236785-0C2BDD80-CC9E-44E0-B0C5-CA20072D4379

Q35236785-0C4F7A9E-A765-419D-969B-F0B2D592E5E7

Q35236785-11946107-62FF-4311-8095-CE5B0657C83B

Q35236785-20311FF0-6CFC-4279-B52B-492D33C0C367

Q35236785-29BA7EF4-A4DD-4358-BABD-73C58A559423

P304

Q35236785-369324AA-8B8C-4B03-A012-C7CE2BAFE512

P31

Q35236785-0ABA9C90-02BC-4D45-8238-CB70200C12B4

P356

Q35236785-984A697B-4FFB-45B1-AE4B-9EEE96FF70C2

P407

Q35236785-C635DFF6-3047-4915-8B80-31A15BD8025F

P433

Q35236785-D5C1E4BA-F6A9-4F85-AE91-09BA5BCA45E7

P478

Q35236785-01C49B2F-E7C2-4178-BAC6-15D8D9576AE0

P50

Q35236785-32346A42-884D-4A25-8A8A-276AE8EBDBFB

Q35236785-584F5F97-399D-4A6C-9F4B-06B7A05AB007

Q35236785-773984AE-FABE-4646-88C3-2008ECD2B76C

Q35236785-834FE0D3-E8FD-438F-8F38-2C17F650A90D

P577

Q35236785-94553251-6DDE-40D9-ABCF-DD27AB7E5C76

P5875

Q35236785-9648359D-C16A-4EEF-B5E6-0D9B6FA70150

P698

Q35236785-A6590C8A-8F65-47FE-ADAF-393E81A65494

P921

Q35236785-069B1F81-967A-4DDD-A3E2-BF36D96CBA1D

P932

Q35236785-CD12CEBD-4594-4439-8D6E-508C880B4F6A

P356

P1433

Cancer Medicine

P1476

PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer

@en

P2093

Alex Duval

http://www.w3.org/2001/XMLSchema#string

Anne-Marie Bouvier

http://www.w3.org/2001/XMLSchema#string

Come Lepage

http://www.w3.org/2001/XMLSchema#string

Delphine Lecorre

http://www.w3.org/2001/XMLSchema#string

Gilles Manceau

http://www.w3.org/2001/XMLSchema#string

Gérard Milano

http://www.w3.org/2001/XMLSchema#string

Janick Selves

http://www.w3.org/2001/XMLSchema#string

Laetitia Marisa

http://www.w3.org/2001/XMLSchema#string

Laurent Martin

http://www.w3.org/2001/XMLSchema#string

Marie-Christine Etienne-Grimaldi

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

AKT/PKB signaling: navigating downstream

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.

KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

The selective class I PI3K inhibitor CH5132799 targets human cancers harboring oncogenic PIK3CA mutations.

High frequency of mutations of the PIK3CA gene in human cancers

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival

P304

371-382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.370

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Pierre Laurent-Puig

Sylviane Olschwang

Dominique Guenot

P577

2015-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271709348

http://www.w3.org/2001/XMLSchema#string

P698

25641861

http://www.w3.org/2001/XMLSchema#string

P921

P932

4380963

http://www.w3.org/2001/XMLSchema#string